Brii Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	606.84	1,003	489.65	1,191	2,855
Short-Term Investments	1,333	1,317	2,171	1,807	499.65
Cash & Short-Term Investments	1,940	2,320	2,661	2,997	3,355
Cash Growth	-16.41%	-12.79%	-11.23%	-10.65%	217.99%
Other Receivables	-	-	71.09	57.72	51.52
Receivables	-	-	71.09	57.72	51.52
Other Current Assets	23.07	93.81	51.03	21.79	7.68
Total Current Assets	1,963	2,414	2,783	3,077	3,414
Property, Plant & Equipment	14.17	14.3	5.61	19.52	33.44
Long-Term Investments	7.43	9.2	142.44	146.03	152.03
Other Intangible Assets	298.02	179.71	267.42	146.89	9.51
Other Long-Term Assets	77.38	89.3	-	2.51	2.79
Total Assets	2,360	2,707	3,198	3,392	3,612
Accrued Expenses	24.74	52.94	68.63	150.87	205.83
Current Portion of Leases	5.04	4.9	3.16	9.5	8.97
Current Income Taxes Payable	1.21	1.19	2.01	1.86	1.65
Current Unearned Revenue	-	16.94	50.63	54.68	52.88
Other Current Liabilities	1.33	1.46	1.44	12.2	11.38
Total Current Liabilities	32.31	77.42	125.87	229.11	280.71
Long-Term Debt	-	17.97	-	-	-
Long-Term Leases	3.89	5.15	-	3.16	12.65
Long-Term Unearned Revenue	-	-	-	2.08	7.08
Total Liabilities	36.2	100.55	125.87	234.35	300.44
Common Stock	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	9,402	9,390	9,377	9,352	9,317
Retained Earnings	-7,473	-7,205	-6,697	-6,522	-6,038
Treasury Stock	-16.9	-0	-0.07	-	-
Comprehensive Income & Other	463.45	472.27	439.28	364.69	63.71
Total Common Equity	2,376	2,657	3,119	3,195	3,343
Minority Interest	-52.32	-50.88	-46.66	-37.12	-31.65
Shareholders' Equity	2,323	2,606	3,072	3,157	3,311
Total Liabilities & Equity	2,360	2,707	3,198	3,392	3,612
Total Debt	8.93	28.02	3.16	12.66	21.62
Net Cash (Debt)	1,931	2,292	2,658	2,985	3,333
Net Cash Growth	-15.78%	-13.74%	-10.96%	-10.45%	-
Net Cash Per Share	2.67	3.14	3.65	4.13	7.59
Filing Date Shares Outstanding	721.18	731.31	729.39	727.2	720.29
Total Common Shares Outstanding	721.18	731.31	729.39	727.2	720.29
Working Capital	1,930	2,337	2,657	2,848	3,133
Book Value Per Share	3.29	3.63	4.28	4.39	4.64
Tangible Book Value	2,078	2,477	2,852	3,048	3,333
Tangible Book Value Per Share	2.88	3.39	3.91	4.19	4.63
Machinery	3.31	3.71	0.34	0.34	0.34
Construction In Progress	1.53	-	-	-	-
Leasehold Improvements	24.84	24.84	24.84	24.84	24.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.